Harnessing Europe’s untapped potential: small and medium pharma

EUCOPE asks the European Commission to put research at the heart of its Pharmaceutical Strategy

The European Commission’s Pharmaceutical Strategy for Europe must:

• Provide ambitious measures to foster research in rare diseases and other disease areas for which we currently have no cure.
• Harness the potential of small and medium pharmaceutical and medical technology companies.
• Ensure that there is a supportive legal and regulatory framework to nurture their growth.

Against the backdrop of the European Commission’s roadmap to a Pharmaceutical Strategy, EUCOPE is asking the Commission to leverage this opportunity to harness the potential of small and medium sized pharmaceutical and medical technology companies in tackling unmet needs.

A coherent strategy that harness Europe’s untapped potential: small and medium pharma